TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive Centers Program Debate Turns Into Full Review Of All issues; Massive Survey, Hearings Planned October 23, 1987